Terrestrosin D is primarily studied for its anticoagulant properties, particularly its ability to inhibit platelet aggregation. This makes it a subject of interest in the development of therapies for cardiovascular diseases, where abnormal blood clotting is a concern. It has shown potential in reducing the risk of thrombosis by interfering with key pathways involved in blood clot formation. Research also suggests possible anti-inflammatory and anticancer activities, though these effects are less characterized and require further investigation. Due to its biological activity, Terrestrosin D is used in scientific research to explore mechanisms of coagulation and platelet function, and may serve as a lead compound for designing new antithrombotic drugs.